BE PHARMACEUTICALS AG is recalling 41,148 vials of Pantoprazole Sodium for Injection (40mg) due to a lack of sterility assurance. The recall was initiated because small cracks were found in some vials, causing the powder inside to become discolored. No incidents or injuries have been reported to date in connection with this issue.
A crack in a vial can compromise its sterile seal, potentially allowing bacteria or other contaminants to enter the medication. Injecting a drug that is not sterile poses a high risk of causing serious, life-threatening infections.
Rx Only medication manufactured in Switzerland and India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.